116 related articles for article (PubMed ID: 37626092)
1. Correction: Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
Tsuji N; Hosokawa K; Urushihara R; Tanabe M; Zaimoku Y; Katagiri T; Ozawa T; Takamatsu H; Ishiyama K; Yamazaki H; Kishi H; Ogawa S; Nakao S
Leukemia; 2023 Oct; 37(10):2143. PubMed ID: 37626092
[No Abstract] [Full Text] [Related]
2. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
Tsuji N; Hosokawa K; Urushihara R; Tanabe M; Zaimoku Y; Katagiri T; Ozawa T; Takamatsu H; Ishiyama K; Yamazaki H; Kishi H; Ogawa S; Nakao S
Leukemia; 2022 Jun; 36(6):1666-1675. PubMed ID: 35474098
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome.
Saunthararajah Y; Nakamura R; Nam JM; Robyn J; Loberiza F; Maciejewski JP; Simonis T; Molldrem J; Young NS; Barrett AJ
Blood; 2002 Sep; 100(5):1570-4. PubMed ID: 12176872
[TBL] [Abstract][Full Text] [Related]
4. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
[TBL] [Abstract][Full Text] [Related]
5. HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.
Battiwalla M; Wang T; Carreras J; Deeg HJ; Ayas M; Bajwa RP; George B; Gupta V; Pasquini R; Schrezenmeier H; Passweg JR; Schultz KR; Eapen M
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1401-6. PubMed ID: 22387349
[TBL] [Abstract][Full Text] [Related]
6. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance].
Cui JX; Pei MF; Zhang GS; Xu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen DR15 is associated with reduced relapse rate and improved survival after human leukocyte antigen-identical sibling hematopoietic stem cell transplantation.
Stern M; Passweg J; Tiercy JM; Genitsch A; Meyer-Monard S; Heim D; Tichelli A; Gratwohl A; Nissen-Druey C
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1169-75. PubMed ID: 17085310
[TBL] [Abstract][Full Text] [Related]
8. [Aplastic anemia complicated with ulcerative colitis].
Shimada T; Maeda T; Ishikawa M; Okamura D; Ito Y; Wakimoto N; Nakamura Y; Kawai N; Ino H; Jinnai I; Mori S; Matsuda A; Bessho M
Rinsho Ketsueki; 2012 Feb; 53(2):224-8. PubMed ID: 22450583
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemia.
Yoroidaka T; Hosokawa K; Imi T; Mizumaki H; Katagiri T; Ishiyama K; Yamazaki H; Azuma F; Nanya Y; Ogawa S; Nakao S
Leukemia; 2021 Nov; 35(11):3257-3267. PubMed ID: 33824463
[TBL] [Abstract][Full Text] [Related]
10. HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.
Battiwalla M; Ellis K; Li P; Pavletic SZ; Akpek G; Hematti P; Klumpp TR; Maziarz RT; Savani BN; Aljurf MD; Cairo MS; Drobyski WR; George B; Hahn T; Khera N; Litzow MR; Loren AW; Saber W; Arora M; Urbano-Ispizua A; Cutler C; Flowers ME; Spellman SR
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1302-8. PubMed ID: 22414493
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR2 Frequency Increase in Severe Aplastic Anemia Patients is Mainly Attributed to the Prevalence of DR15 Subtype.
Kapustin SI; Popova TI; Lyschov AA; Togo AV; Abdulkadyrov KM; Blinov MN
Pathol Oncol Res; 1997; 3(2):106-108. PubMed ID: 11173635
[TBL] [Abstract][Full Text] [Related]
12. [Hematopoietic stem-cell transplantation in aplastic anemia].
Hernández-Rivera EG
Rev Invest Clin; 2005; 57(2):298-304. PubMed ID: 16524071
[TBL] [Abstract][Full Text] [Related]
13. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
14. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor polymorphism affects transplantation outcome in patients with myelodysplastic syndrome but not in those with chronic myelogenous leukemia, independent of the presence of HLA-DR15.
Newell LF; Gooley T; Hansen JA; Stirewalt DL; Petersdorf EW; Deeg HJ
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1700-6. PubMed ID: 20541027
[TBL] [Abstract][Full Text] [Related]
16. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia.
Nakao S; Takamatsu H; Chuhjo T; Ueda M; Shiobara S; Matsuda T; Kaneshige T; Mizoguchi H
Blood; 1994 Dec; 84(12):4257-61. PubMed ID: 7994040
[TBL] [Abstract][Full Text] [Related]
17. Isolation of a T-cell clone showing HLA-DRB1*0405-restricted cytotoxicity for hematopoietic cells in a patient with aplastic anemia.
Nakao S; Takami A; Takamatsu H; Zeng W; Sugimori N; Yamazaki H; Miura Y; Ueda M; Shiobara S; Yoshioka T; Kaneshige T; Yasukawa M; Matsuda T
Blood; 1997 May; 89(10):3691-9. PubMed ID: 9160674
[TBL] [Abstract][Full Text] [Related]
18. Acquired aplastic anemia complicated with anti-glomerular basement membrane disease successfully treated with immunosuppressive therapy: a case report.
Matsui K; Kamata W; Mochida Y; Ishioka K; Moriya H; Hidaka S; Ohtake T; Tamai Y; Kobayashi S
BMC Nephrol; 2022 Apr; 23(1):136. PubMed ID: 35392836
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance and origin of leukocytes that lack HLA-A allele expression in patients with acquired aplastic anemia.
Maruyama H; Katagiri T; Kashiwase K; Shiina T; Sato-Otsubo A; Zaimoku Y; Maruyama K; Hosokawa K; Ishiyama K; Yamazaki H; Inoko H; Ogawa S; Nakao S
Exp Hematol; 2016 Oct; 44(10):931-939.e3. PubMed ID: 27250585
[TBL] [Abstract][Full Text] [Related]
20. Donor HLA-DR Drives the Development of De Novo Autoimmunity Following Lung and Heart Transplantation.
Jankowska Gan E; Agashe VV; Lema DA; Zhou Y; Gonzalez Bosc L; Sullivan JA; Greenspan DS; Burlingham WJ
Transplant Direct; 2020 Oct; 6(10):e607. PubMed ID: 33062840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
